T1	Participants 446 762	200 evaluable patients, 51 were treated intramuscularly (IM) with 3 x 10(6) U (3 MU)/m2 daily for 3 weeks (total dose 63 MU/m2), 50 received subcutaneous thrice-weekly injections of 3 MU/m2 for 4 weeks (total dose 36 MU/m2), 51 underwent diathermocoagulation, and 48 were not treated and were used as a control group
T2	Participants 140 261	Two hundred three patients (median age 26 years; range 18-45) with untreated multiple and widespread anogenital condyloma
